Human Genome Sciences, Inc. (HGSI) Misses Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts HGSI Hot Sheet
Price: $14.24 --0%
Financial Fact:
Research and development expenses: 35.44M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Research and development expenses: 35.44M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Human Genome Sciences, Inc. (NASDAQ: HGSI) reported Q1 EPS of ($0.47), $0.08 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $47.1 million versus the consensus estimate of $45.94 million.
For earnings history and earnings-related data on Human Genome Sciences, Inc. (HGSI) click here.
For earnings history and earnings-related data on Human Genome Sciences, Inc. (HGSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Broadcom shares fall 3% after revenue forecast misses estimates
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
